To investigate biological shifts associated with PARP1, we compared the whole-genome expression profiles of patients with high PARP1 expression and patients with low PARP1 expression at diagnosis (GSE13159, 66 CML patients’ mononuclear cells of the bone marrow). This evidence concerns the gene PARP1 and chronic myelogenous leukemia, BCR-ABL1 positive.